David Coleman

High-dose rifapentine with moxifloxacin for pulmonary tuberculosis.

P. Butcher, M. Hatherill, S. Charalambous, 2014, The New England journal of medicine.

Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial

M. Pagano, C. Contreras, R. Calderón, 2016, BMC Infectious Diseases.

A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis.

D. Mitchison, R. Rustomjee, G. Davies, 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Clinical Application of Whole-Genome Sequencing To Inform Treatment for Multidrug-Resistant Tuberculosis Cases

Jason Hinds, Philip D. Butcher, Neil G. Stoker, 2015, Journal of Clinical Microbiology.

Use of whole-genome sequencing to distinguish relapse from reinfection in a completed tuberculosis clinical trial

A. Witney, P. Butcher, N. Stoker, 2017, BMC Medicine.